Clinical Trials at Illinois Cancer Specialists
As of August 2026, 16 paid clinical trials are recruiting at Illinois Cancer Specialists, located at 880 W CENTRAL RD, SUITE 8200, ARLINGTON HEIGHTS, IL 60005-2355, phone (847) 259-4482 in Arlington Heights, Illinois. Active studies at this site cover conditions such as Colorectal Neoplasms, Breast Cancer and Cardiovascular Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
16 clinical trials at Illinois Cancer Specialists
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Common conditions studied in Arlington Heights
- Colorectal Neoplasms (3 active studies)
- Breast Cancer (2 active studies)
- Cardiovascular Disease (2 active studies)
- Heart Failure (2 active studies)
- Metastatic Colorectal Cancer (2 active studies)
- Ovarian Neoplasms (2 active studies)
Leading research sponsors in Arlington Heights
- AstraZeneca
- Boehringer Ingelheim
- Pfizer
- Amgen
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Arlington Heights?
There are approximately 35 recruiting clinical trials in Arlington Heights, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Arlington Heights pay participants?
Most recruiting trials in Arlington Heights compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Arlington Heights?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Arlington Heights?
The most common conditions under active study in Arlington Heights include Colorectal Neoplasms (3), Breast Cancer (2), Cardiovascular Disease (2), Heart Failure (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Arlington Heights?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington Heights on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Arlington Heights?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Arlington Heights?
Recruiting research sites in Arlington Heights include Illinois Cancer Specialists, Northwest Community Hospital, Endeavor Health-Northwest Community Healthcare, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Arlington Heights right now?
The largest active categories in Arlington Heights are Cancer & tumors (19), Cardiovascular (5), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Illinois Cancer Specialists?
Illinois Cancer Specialists is located at 880 W CENTRAL RD, SUITE 8200, ARLINGTON HEIGHTS, IL 60005-2355. Use the Google Maps link in the intro above to get directions.
How do I contact Illinois Cancer Specialists?
You can reach Illinois Cancer Specialists by phone at (847) 259-4482. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.